NCT05435248
- Conditions
- Advanced or Metastatic NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Clinical trial condition
Advanced or Metastatic NSCLC
Explore clinical trials studying Advanced or Metastatic NSCLC. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Advanced or Metastatic NSCLC trial results
NCT04177290
- Conditions
- Advanced or Metastatic NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- The First Affiliated Hospital of Bengbu Medical College Bengbu, China
Active, Not Recruiting
Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer
NCT04612751
- Conditions
- Advanced or Metastatic NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Santa Ana, California, United States
- Research Site St Louis, Missouri, United States
- Research Site Hackensack, New Jersey, United States
NCT05941897
- Conditions
- Advanced or Metastatic NSCLC, Bronchial Diseases, Bronchial Neoplasms, +9 more
- Locations
-
- Research Site Moscow, Russia
- Research Site Moscow, Russia
- Research Site Moscow, Russia
- Research Site Moscow, Russia
Active, Not Recruiting
Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)
NCT04526691
- Conditions
- Advanced or Metastatic NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- Mayo Clinic Scottsdale, Arizona, United States
- City of Hope Duarte, California, United States
- Johns Hopkins Kimmel Cancer Center Washington D.C., District of Columbia, United States
- Mayo Clinic Jacksonville, Florida, United States